Abstract
We analysed factors that might influence patients' and physicians' decisions against the initiation of guideline adherent adjuvant endocrine therapy (ET). In a prospective multi-centre study, including four certified breast cancer centres in Germany, patients with primary breast cancer were included from 2009 to 2012. Patients completed a questionnaire prior to surgery, adjuvant therapy, and 6months after adjuvant therapy. This questionnaire assessed health-related quality of life (QoL), psychiatric co-morbidity, demographic characteristics, and the intensity of fear for ET. Guideline adherence was classified based on an algorithm derived from international guidelines. The tumour board's (TB) decisions against or for ET was documented. The TB was blinded regarding the guideline results. In 666 patients, adjuvant ET was indicated according to the guideline recommendations. The TB decided in 92.3% (n=615) of those that adjuvant ET was indicated. TB's decision against ET was associated with the younger age of patients (OR=0.5; 95% CI 0.3-0.9) and poor QoL (OR=1.7; 95% CI 1.0-2.8). In 93 patients, ET was not indicated according to the guidelines, and the TB decided in 84 of those not to prescribe ET. The TB decided in 93.4% of the cases according to the guidelines. Of the patients, where the TB prescribed ET, 5% (n=31) decided against ET. This decision was associated with fear of ET (OR=2.2; 95% CI 1.0-5.2) and higher age (OR 9; 95% CI 1.0-48.1). Psychiatric co-morbidity (OR=1.8; 95% CI 0.7-4.2), poor QoL (OR=0.4; 95% CI 0.2-1.2), and education (OR=1.2; 95% CI 0.5-2.6) were not associated with the decision. Guideline adherent implementation of adjuvant ET is high. Physicians' decision against ET is mainly associated with patients' younger age and poor quality of life, whereas patients' decision, once the TB decided to initiate ET and if ET is indicated by guidelines, is associated with higher age and fear of ET.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.